Forward-looking investment in a new combined heat and power unit at the Wolfratshausen site
1.12.2009
At their Wolfratshausen site Haupt Pharma has put a new combined heat and power unit (CHPU) into operation, which is a system that generates both electricity (power) and heat. This is referred to as combined production, as the...[more]
New separate production area for sex hormone-containing solids sets standards for EHS and GMP
28.09.2009
Handling of sex hormones as highly potent pharmacologically active substances requires increasingly complex facilities and machinery to protect the product, the workforce and the environment. Haupt Pharma meets these demands by...[more]
Dr. Robert Fritsch is taking over as the sole Managing Director of Haupt Pharma Brackenheim GmbH
24.09.2009
With immediate effect Dr. Robert Fritsch is the sole Managing Director of Haupt Pharma Brackenheim GmbH. After an extensive period of preparation for succeeding Mr Karl-Heinz Renner he was appointed the second Managing Director...[more]
We fix toaster – no ordinary exhibition
23.09.2009
Last Friday the retrospective by Norman T. White (Canada), winner of the third d.velop digital art award [ddaa], opened at the Weserburg | Museum of Modern Art in Bremen. we fix toaster – the title provides an indication that...[more]
New filling system for sterile products guarantees the highest quality and efficiency
24.06.2009
The requirements for quality and efficiency in the manufacturing of sterile products are steadily becoming more stringent. Haupt Pharma meets these demands by continuously investing in modern technologies. The performance of...[more]
New packaging line offers even greater flexibility
29.04.2009
High performance and efficiency are important aspects for a successful collaboration in contract manufacturing.
To continue to be a competent contact partner for our customers in the future, Haupt Pharma Brackenheim GmbH has...[more]
Mr. Werner Bürk has resigned as Chief Sales & Development Officer
6.03.2009
Mr. Werner Bürk has resigned as Chief Sales & Development Officer on March 6th with immediate effect for personal reasons. The board of directors and the supervisory board respect his decision and wish him all the best for his...[more]
Haupt Pharma acquires Pfizer’s Plant in Italy
4.02.2009
Product portfolio and international business to be expanded
Berlin, February 4, 2009 – Haupt Pharma AG, one of the world's largest pharmaceutical contract manufacturers and developers, announced today that it has completed the...[more]
Dr. Karl Heinz Brücher becomes the Chief Technical Operations Officer (CTOO) of Haupt Pharma AG
1.02.2009
Dr. Brücher will become the CTOO on February 1, 2009 and will thus be a member of the executive board of Haupt Pharma AG. The core task of Dr. Brücher will be to ensure that the processing of customer orders is...[more]
Second Managing Director strengthens the top management of Haupt Pharma Wülfing GmbH
1.02.2009
The executive board of Haupt Pharma AG has appointed Dr. Thomas Julien as Managing Director of Haupt Pharma Wülfing GmbH with effect from January 8, 2009. Dr. Julien will take over the management of the company jointly with the...[more]
Dr. Thomas Andresen appointed new Managing Director of Haupt Pharma Amareg
7.01.2009
The executive committee of Haupt Pharma AG has appointed Dr Thomas Andresen new Managing Director of Haupt Pharma Amareg GmbH effective from January 1, 2009. After his pharmaceutical studies in Freiburg and receiving a license as...[more]
